![Anthony L. Kiorpes](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anthony L. Kiorpes
Corporate Officer/Principal at American Board of Toxicology
Network origin in Anthony L. Kiorpes first degree
Entity | Entity type | Industry | |
---|---|---|---|
American Board of Toxicology
2
| Non-Profit Organization | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Anthony L. Kiorpes via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ICOS Corp.
![]() ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Pharmaceuticals: Other | Corporate Officer/Principal | |
VentiRx Pharmaceuticals, Inc.
![]() VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Oregon Health & Science University | College/University | Doctorate Degree | |
University of Cincinnati (Ohio) | College/University | Doctorate Degree | |
Washington State University | College/University | Graduate Degree | |
Society for Risk Analysis | Corporate Officer/Principal | ||
Academy of Toxicological Sciences | Corporate Officer/Principal | ||
United States Environmental Protection Agency | General Government | Corporate Officer/Principal | |
Toxicology Excellence for Risk Assessment
![]() Toxicology Excellence for Risk Assessment Miscellaneous Commercial ServicesCommercial Services Toxicology Excellence for Risk Assessment provides human health scientific research and development services. It provides risk managers, legislators, and ordinary citizens with the toxicology information they need to make important decisions about chemical safety. The company was founded in 1995 by Michael L. Dourson and is headquartered in Cincinnati, OH. | Miscellaneous Commercial Services | Founder |
Statistics
International
United States | 10 |
Sectoral
Consumer Services | 4 |
Health Technology | 3 |
Government | 2 |
Commercial Services | 2 |
Operational
Corporate Officer/Principal | 6 |
Doctorate Degree | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Most connected contacts
Insiders | |
---|---|
Michael L. Dourson | 6 |
Gregory N. Dietsch | 5 |
- Stock Market
- Insiders
- Anthony L. Kiorpes
- Company connections